In August 2025, headlines announced that ibuprofen and acetaminophen “supercharge” antibiotic resistance. The claim spread quickly because the drugs are in nearly every medicine cabinet. It also went further than the research supports.
The underlying study is real and interesting. It was a laboratory experiment on bacteria, not a trial in people. Understanding the gap between those two things is the key to reading the story about painkillers antibiotic resistance accurately, and it does not require stopping any medication.
What the New Study Actually Tested
Researchers at the University of South Australia published the work in npj Antimicrobials and Resistance in August 2025. The team, led by Henrietta Venter, was interested in residential aged care, where residents often take many medications at once, including antibiotics.
They tested nine commonly used non-antibiotic medications: ibuprofen, diclofenac, acetaminophen (paracetamol), furosemide, metformin, atorvastatin, tramadol, temazepam, and pseudoephedrine. Each was applied at concentrations meant to resemble those in the human gut. The bacterium was Escherichia coli, a common gut organism and a leading cause of urinary tract infections. The antibiotic was ciprofloxacin, a widely used broad-spectrum drug.
Two strains were used. One was a laboratory reference strain, and the other was isolated from a fecal sample from a retirement community resident.
The main findings
- Ibuprofen and acetaminophen significantly increased the mutation frequency of E. coli in the presence of ciprofloxacin.
- The resulting mutants showed high-level resistance to ciprofloxacin.
- Whole-genome sequencing found mutations in three genes: gyrA, marR, and acrR. The latter two were linked to overproduction of an efflux pump called AcrAB-TolC, which pushes antibiotics out of the cell.
- Exposure to two of the non-antibiotic drugs together increased mutation rates and resistance levels further.
The study did not test people. It did not measure infections. It examined bacteria in a controlled experiment.
Why the Headline Can Mislead
“Supercharging” implies a large, proven effect on human health. Several distinctions argue for caution.
| What the study showed | What it did not show |
|---|---|
| Higher mutation frequency in E. coli under lab conditions | That people taking painkillers develop resistant infections |
| Resistance to one antibiotic, ciprofloxacin | Effects on other antibiotics or bacteria |
| Association with known resistance mechanisms | Proof of clinical harm |
| Effects at modeled gut concentrations | Real-world dose, timing, and duration effects |
The lead author has said the finding does not mean people should stop using these medications. The concern raised was about combinations of multiple drugs alongside antibiotics, particularly in aged care.
Laboratory findings often fail to replicate in living organisms. The human gut contains trillions of microbes, an immune system, and variable drug concentrations. A mutation rate measured in a flask is a signal to investigate, not a clinical outcome. Other research on non-antibiotic drugs and resistance has produced results pointing in different directions depending on the experimental setup.
How Antibiotic Resistance Normally Develops
To judge the new finding, it helps to know the established causes.
- Mutation. Random changes in bacterial DNA occasionally help a cell survive an antibiotic.
- Selection pressure. When antibiotics kill susceptible bacteria, resistant ones survive and multiply.
- Horizontal gene transfer. Bacteria can pass resistance genes to each other, even across species.
- Antibiotic exposure. Overuse and misuse remain the primary driver worldwide, in medicine and agriculture.
- The gut microbiome. The gut is a reservoir where resistant bacteria and their genes can accumulate.
The scale of the problem is large. A global analysis published in The Lancet estimated that 4.95 million deaths were associated with bacterial antimicrobial resistance in 2019. The WHO treats resistance as one of the top global public health threats.
Where Painkillers Enter the Research
Non-antibiotic medications make up roughly 95% of the pharmaceutical market. For years, scientists assumed they had no effect on bacteria. That assumption has weakened. A report cited in the Australian paper found that more than 200 commonly used drugs had antibiotic-like effects on gut bacteria.
Researchers now ask whether non-antibiotic drugs can influence bacterial stress responses and mutation. Possible mechanisms include triggering stress pathways that raise mutation rates or increasing efflux pump activity. Earlier work had also flagged ibuprofen residues in wastewater as a potential environmental concern.
The Australian study adds an important piece by testing multiple drugs and combinations at gut-relevant concentrations. It remains one experiment.
The Role of the Gut Microbiome
Medications can reshape the gut microbiome, the community of bacteria living in the intestines. Some drugs suppress certain species and allow others to expand. Proton pump inhibitors, metformin, and antibiotics themselves all have documented microbiome effects.
What is established: many drugs alter microbial composition. What is hypothesized: that some of these shifts increase resistance gene transfer or the survival of resistant strains. The evidence linking specific painkillers to resistant infections in people is not yet available.
What This Does Not Mean for Everyday Painkiller Users
This point matters most for readers. The findings do not establish that occasional use of ibuprofen or acetaminophen causes antibiotic-resistant infections in humans.
Several practical points follow:
- People should not stop prescribed medication because of this study.
- Pain relievers treat real problems. Untreated pain and fever carry their own risks.
- The findings are most relevant to research on polypharmacy, especially in older adults taking many drugs.
- Anyone with questions about their medication combinations can ask a pharmacist or physician.
Acetaminophen and ibuprofen also have well-known safety limits, including liver risk from excess acetaminophen and stomach or kidney risks from NSAIDs. Following label and clinician instructions remains the sensible approach.
Using Painkillers and Antibiotics Together Safely
Millions of people take a pain reliever while on an antibiotic, and the practice is usually fine. Practical safety still has more to do with the label than with the resistance study.
- Acetaminophen has a daily maximum that appears on the package. Exceeding it raises the risk of liver injury, and many combination cold products contain it too.
- Ibuprofen and other NSAIDs can irritate the stomach and affect the kidneys, especially in older adults, people who are dehydrated, and those on certain blood pressure medications.
- Fluoroquinolone antibiotics, the class that includes ciprofloxacin, carry a labeled interaction with some NSAIDs that may raise the risk of seizures. Pharmacists check for this when filling prescriptions.
Ciprofloxacin itself deserves attention. In 2016, the FDA advised that fluoroquinolones should be reserved for patients with certain infections, such as uncomplicated sinusitis, bronchitis, or urinary tract infections, who have no alternative treatment options, because of the risk of serious side effects. That guidance is another reminder that antibiotic choice is a clinical decision.
Questions worth asking a pharmacist
- Are any of my current medications known to interact with this antibiotic?
- Is it safe to take a pain reliever alongside it, and which one is best for me?
- What is the maximum daily dose of each product I use?
- Should I avoid anything while I finish the course?
A pharmacist can review the whole list, including supplements and over-the-counter products. Older adults who take many medications can also ask for a periodic medication review, which is the setting that inspired the Australian study.
Why Antibiotic Stewardship Still Matters
The proven route to resistance is unnecessary antibiotic exposure. CDC and WHO guidance emphasizes several habits.
- Take antibiotics only when they are indicated. They do not work on viruses such as colds and flu.
- Follow the prescriber’s instructions. Ask how long to take the course, since guidance on duration has shifted for some infections.
- Never share antibiotics. A drug prescribed for one person may be wrong for another.
- Do not use leftovers. Old antibiotics may be the wrong drug, dose, or duration.
- Prevent infection. Vaccination and handwashing reduce the need for antibiotics.
These steps address the primary driver of resistance. A laboratory signal about painkillers does not change them.
How Scientists Judge a Study Like This
A finding gains weight as it moves from bench to bedside. Laboratory studies sit near the start of that path.
| Step | Question it answers |
|---|---|
| Laboratory experiment | Can the effect occur under controlled conditions? |
| Replication by other groups | Does the result hold up elsewhere? |
| Animal or gut model studies | Does it occur in a living, more complex system? |
| Observational human studies | Do people exposed to the drug show more resistance? |
| Clinical trials or large cohorts | Does the effect change patient outcomes? |
The Australian study used two E. coli strains, nine drugs, and one antibiotic. That is a solid design for a first look, and it is a small slice of the possible combinations. Independent replication with other bacteria, other antibiotics, and different concentrations would show how general the effect is.
Peer review is a useful filter, but it does not settle a question. Many promising laboratory results never translate into human benefit or harm. Readers can keep that in mind when a single study generates a dramatic headline.
What Researchers Need to Study Next
| Research need | Why it matters |
|---|---|
| Human studies | To see whether lab effects occur in people |
| Real-world drug combinations | Patients rarely take a single medication |
| Dose and duration | Occasional use differs from chronic use |
| Gut microbiome effects | Resistance may depend on whole communities |
| Clinical outcomes | Infections and treatment failures are what ultimately matter |
Studies in aged care residents, where polypharmacy is common, would be especially informative.
A Signal Worth Following, Not a Reason to Panic
The study opens a legitimate question about how ordinary medicines interact with bacteria. It gives researchers a hypothesis and a mechanism to test. It does not provide clinical guidance.
Until human evidence arrives, established advice holds: use antibiotics wisely, take other medications as directed, and talk to a pharmacist or physician about concerns.
Disclaimer: This article is for general information and is not medical advice. Do not stop or change prescribed medication without speaking to a healthcare professional. The research discussed was conducted in laboratory conditions and does not establish effects in humans.
FAQ
Q: Can ibuprofen cause antibiotic resistance?
A: A 2025 laboratory study found ibuprofen increased mutations in E. coli exposed to ciprofloxacin. That does not show it causes resistant infections in people. Human studies are needed.
Q: Can paracetamol cause antibiotic resistance?
A: The same study found acetaminophen (paracetamol) raised mutation frequency and resistance in lab bacteria. Effects in humans have not been demonstrated.
Q: Should people stop taking painkillers?
A: No. The researchers themselves said the findings do not mean people should stop using these medications. Anyone with concerns about combinations should ask a pharmacist or doctor.
Q: What did the latest study actually find?
A: Under experimental conditions, ibuprofen and acetaminophen increased E. coli mutations and high-level ciprofloxacin resistance. Combined exposure amplified the effect. The work was done in bacteria, not people.
Q: Does laboratory evidence prove the same effect occurs in humans?
A: No. Human bodies contain immune defenses, complex microbiomes, and variable drug levels. Many laboratory findings do not translate into clinical outcomes.
Q: Why does antibiotic resistance develop?
A: Resistance arises when bacteria mutate or acquire genes that let them survive antibiotics, and exposure selects for those survivors. Overuse and misuse of antibiotics are the main drivers.
Q: Does taking antibiotics for a cold help?
A: No. Colds and flu are caused by viruses, which antibiotics cannot treat. Unnecessary use contributes to resistance.
Q: Who might be most affected by drug interaction concerns?
A: Older adults taking many medications, especially in aged care settings, are the group researchers highlighted. Regular medication reviews with a pharmacist are a practical safeguard.